Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin in Drug-Resistant Epilepsy
NCT04763070Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Oct 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ciprofloxacin in epilepsy, sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Changes in seizure frequency registered in questionnaire at 4 weeks, Changes in quantity of microbial DNA extracted from stool samples at 7 days and 1 more. Started Oct 2020; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT04763070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04763070.